PMID: 18717040Aug 23, 2008Paper

Participation of metallo-beta-lactamases in resistance to imipenem and meropenem in clinical strains of Pseudomonas aeruginosa and Acinetobacter spp

Wiadomości lekarskie : organ Polskiego Towarzystwa Lekarskiego
Paweł SachaMarcin Zórawski

Abstract

Imipenem and/or meropenem resistance has been observed commonly in nonfermenter species such as Pseudomonas aeruginosa (P. aeruginosa) and Acinetobacter spp. An increasing prevalence of carbapenems resistance mediated by acquired metallo-beta-lactamases (MBLs) is being reported particularly for Gram-negative rods in several countries. The aim of this study was to determine participation of MBLs in resistance to carbapenems of P. aeruginosa and Acinetobacter spp. and antimicrobial susceptibility to antibiotics. A total 79 clinical strains of Gram-negative rods (P. aeruginosa and Acinetobacter spp.) with resistance to carbapenems (or reduced susceptibilities) were screen for ability to production of MBLs. Metallo-beta-lactamases were detected by using E-test (IP/IPI). The antibiotic susceptibilities determined by two methods: disc-diffusion and E-tests (only carbapenems). Three of 79 strains (3.8%) were MBLs-positive. All of MBLs-positive strains were characterized by multiresistance to tested antibiotics. Cefepime and gentamicin were the most active antibiotics. The results of susceptibility testing of MBLs-negative strains (carbapenems-resistant) showed the highest percentage of susceptibility to cefepime - 92.3% P. aeruginosa ...Continue Reading

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.